Millionaire Son in Law Chapter 2616
Welcome to Millionaire Son in Law Chapter 2616. We hope you enjoy reading.
- Charlie discusses his substantial financial holdings.
- JX Pharmaceutical’s product success receives global recognition.
- Future plans for business growth and profit potential are explored.
Please read the chapter.
A discussion about significant financial resources. The success of a pharmaceutical product is highlighted. Business expansion and future profit potential are explored.
Pollard felt that Charlie should have an Emgrand Group and the 10 billion funds in his hands.
When these two things add up, it is just over 100 billion and nodded, and the possibility of trying to compete with the Wade Family or the Su Family is almost zero.
Charlie smiled slightly at this time and said, “You said Professor Watt, I still have tens of billions of funds in my hands. Moreover, I have a pharmaceutical company with good momentum and an annual profit of 10 billion It may even exceed 100 billion next year, and it is entirely possible to continue to supply blood for my other projects.”
Pollard said in surprise: “You have a pharmaceutical company with an annual profit of over 10 billion? What’s its name?”
Charlie said, “JX Pharmaceutical, I wonder if Professor Watt has heard of it?”
Pollard was even more shocked, blurting out, “It’s the company that produces JX Weisan?!”
Charlie nodded: “Yes, the current core product is JX Weisan.”
“My God!” Pollard exclaimed, and said, “JX Weisan is now well-known worldwide! My gastrointestinal tract has always been a little problematic. I also took a box of Weisan some time ago. It acted immediately. I used to not dare to eat raw, cold, or spicy food. Now I have JX Weisan. What Sichuan cuisine, Hunan cuisine, Yuzhou hot pot, and Japanese cuisine are totally beyond mention… ..”